We are live on
!
Find out more
Pictet Asset Management Portfolio holdings
AUM
$94.8B
1-Year Est. Return
25.09%
This Fund
S&P 500
1 Year Est. Return
+25.09%
AUM
$94.8B
AUM Growth
-$8.22B
(-8%)
Holding
2,167
Top Buys
| 1 | +$565M | |
| 2 | +$416M | |
| 3 | +$264M | |
| 4 |
Arista Networks
ANET
|
+$262M |
| 5 |
Autodesk
ADSK
|
+$235M |
Top Sells
| 1 | +$284M | |
| 2 | +$281M | |
| 3 | +$275M | |
| 4 |
Teradyne
TER
|
+$274M |
| 5 |
KLA
KLAC
|
+$243M |
Sector Composition
| 1 | Technology | 34.66% |
| 2 | Industrials | 14.33% |
| 3 | Healthcare | 12.96% |
| 4 | Financials | 7.97% |
| 5 | Utilities | 7.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SCHW
226
Charles Schwab
SCHW
$159B
| $89.9M | 0.09% |
956,500
-42,935
|
|
||
227
Citigroup
C
$245B
| $89M | 0.09% |
784,856
-113,958
|
|
||
228
Iron Mountain
IRM
$38.9B
| $88.2M | 0.09% |
864,737
-1,431,228
|
|
||
229
Adobe
ADBE
$78.1B
| $87.5M | 0.09% |
359,796
-262,500
|
|
||
|
TERN
230
DELISTED
Terns Pharmaceuticals
TERN
| $87.3M | 0.09% |
1,655,575
+78,459
|
|
||
231
Bristol-Myers Squibb
BMY
$112B
| $86.9M | 0.09% |
1,432,429
-73,242
|
|
||
232
Toronto Dominion Bank
TD
$196B
| $85.9M | 0.09% |
923,081
-19,455
|
|
||
233
DTE Energy
DTE
$31.4B
| $85.3M | 0.09% |
583,536
-12,435
|
|
||
234
ICICI Bank
IBN
$104B
| $85.3M | 0.09% |
3,294,052
+495,504
|
|
||
235
Capital One
COF
$123B
| $84.9M | 0.09% |
465,375
+97,751
|
|
||
236
Incyte
INCY
$21.7B
| $84.8M | 0.09% |
916,188
-399,478
|
|
||
237
CME Group
CME
$83.7B
| $84.3M | 0.09% |
285,386
+77,148
|
|
||
238
Newmont
NEM
$100B
| $83.5M | 0.09% |
772,367
+92,191
|
|
||
239
PTC Therapeutics
PTCT
$7B
| $80.1M | 0.08% |
1,183,720
+204,763
|
|
||
240
Cognizant
CTSH
$19.6B
| $79.7M | 0.08% |
1,298,864
-154,297
|
|
||
241
Arrowhead Research
ARWR
$11.2B
| $79.6M | 0.08% |
1,273,266
+244,530
|
|
||
242
Amphenol
APH
$200B
| $79.5M | 0.08% |
629,096
+89,454
|
|
||
243
Neurocrine Biosciences
NBIX
$16.7B
| $78.9M | 0.08% |
602,643
-174,291
|
|
||
244
Revvity
RVTY
$11.8B
| $78.6M | 0.08% |
897,343
-466,439
|
|
||
245
Qualcomm
QCOM
$208B
| $77.8M | 0.08% |
604,150
+23,069
|
|
||
246
Alnylam Pharmaceuticals
ALNY
$39.3B
| $77.5M | 0.08% |
237,920
-78,133
|
|
||
247
Pfizer
PFE
$137B
| $76.2M | 0.08% |
2,713,383
-38,136
|
|
||
248
HCA Healthcare
HCA
$86B
| $76.2M | 0.08% |
161,028
+38,961
|
|
||
249
Celestica
CLS
$41.6B
| $75.9M | 0.08% |
269,950
+211,003
|
|
||
250
S&P Global
SPGI
$119B
| $74.9M | 0.08% |
176,065
-29,577
|
|